Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study
Article in Neuro-Oncology Advances (January 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Neuro-Oncology Advances (January 2023)
Article in Oral and Maxillofacial Surgery Cases (June 2022)